PharmaTalkRadio
435 episodes - English - Latest episode: 15 days ago - ★★★★ - 16 ratingsPharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Transforming Cardiovascular Treatment with Pulmonary Delivery
February 05, 2020 19:00 - 16 minutes - 14.3 MBFirst recorded at the 2nd annual Drug Delivery West conference, Dr Carlos Schuler, InCarda Therapeutics discusses transforming cardiovascular treatment with pulmonary delivery. This podcast discusses: Pioneering a novel approach for treating cardiovascular conditions by the oral inhalation routeWill be the ONLY non-invasive, self administered product for acute management of Paroxysmal Atrial Fibrilation, providing rapid cardioversionIn Phase 2: Dose dependent conversion observedWorking on enh...
MRI-Guided Focused Ultrasound and the Delivery of Therapeutics to the Brain
February 05, 2020 14:30 - 32 minutes - 28.9 MBIn this podcast, first recorded at the 2nd annual Drug Delivery West conference, Dr Isabelle Aubert, University of Toronto, provides an introduction to MRI-guided focused ultrasound (MRIgFUS) and reviews applications in preclinical models of neurodegenerative disorders where therapeutic molecules, gene therapy vectors, and progenitor cells are injected intravenously and delivered from the blood to targeted areas of the brain with MRIgFUS. Dr Aubert will describe the seminal work of the Sunnyb...
Better Strategies to Inform Patients on Clinical Research & Trial Participation
January 23, 2020 14:30 - 40 minutes - 36.5 MBBringing clinical research as a care option to patients is arguably the greatest change we can collaborate on to give patients the best choices of care and to help make clinical trial options easier for providers to access. This panel, moderated by Dr Irfan Khan, TrialScout and recorded at the 6th annual Patients as Partners US conference, will explore how to collaborate to create better strategies to inform patients on clinical research and trial participation. Key talking points include: ...
Chief Patient Advocate/Officer: Driving Culture Change from the Top Down
January 23, 2020 14:00 - 32 minutes - 28.4 MBIn this fireside chat, moderated by Ken Getz, Tufts CSDD/CISCRP and recorded at the 6th annual Patients as Partners US conference discusses the following: How do you create a culture that enables new strategic, operating and organizational models to flourish?How do you drive a patient-centric organization while continuing to execute on business imperatives? How do you balance that?How do you drive a patient-centric agenda through the value chain?How do you engage your employees and empower th...
How Novartis Includes Patient Input into All Aspects of a Clinical Study
January 22, 2020 14:30 - 24 minutes - 21.8 MBThis case study presented by Thérèse Johnsen, Novartis and first recorded at the 6th annual Patients as Partners US conference, discusses how the patient perspective was included from the earliest planning of a clinical trial and how it impacted the design, trial sites and the patient experience throughout the study. To learn more about the 7th annual Patients as Partners US conference happening June 29-30, 2020 in Philadelphia, PA please visit www.patientsaspartners.org
Patients as Partners in Clinical Research EU 5 Min Upcoming Conf Summary
January 06, 2020 05:00 - 7 minutes - 6.01 MBThis 5 minute podcast summary helps prepare listeners on what they can expect at the4th Annual Patients as Partners Europe event, taking place January 27th and 28th in London. The venue is the Millennium Gloucester Hotel. In a nutshell, Patient as Partners is the first conference in Europe dedicated to understanding how working with patients can drive greater clinical trial efficiencies throughout the entire medicines development process. It is ultimately about how to reduce risk in the deve...
Partnering with Patients on Clinical Development Protocols
December 20, 2019 20:00 - 19 minutes - 16.8 MBLinda Kollmar, Executive Director, Scientific Medical Patient Perspective - Oncology, Merck, shares with the audience at the 6th annual Patients as Partners US conference, Merck's strategy for bringing on a patient, as an equal stakeholder of their clinical development team, to provide patient input in protocol development and trial design. Ms Kollmar walks the audience through how this was done, the role of the patient employee and the impact it has to date on the clinical development initia...
Improving Clinical Research and Trials Through Pharma/Advocacy Partnerships
December 19, 2019 21:00 - 43 minutes - 38.6 MBThis podcast moderated by Mary Murray, BMS and recorded at the 6th annual Patients as Partners US conference discusses Improving Clinical Research and Trials Though Effective Pharma/Advocacy Partnerships. Topics include: What are the key elements that make for an effective partnership between Industry and Advocacy Groups?What is not getting done or being left on the table to increase partnership value?In relation to clinical trials what can we and what must we learn from existing experiences...
Engaging with Communities to Educate and Enroll Diverse Populations
December 19, 2019 14:00 - 40 minutes - 36.2 MBThis podcast, first recorded at the 6th annual Patients as Partners US conference and moderated by Jan Nissen, Merck discusses the complexities of diversity and waht actions we can take to raise clinical trial awareness and enrollment that is reflective of the demographics of the populations. This panel discusses: What are some examples of how industry has approached diversity such as developing partnerships, education and awareness to identify and address the barriers of diversity?Is indust...
Mapping Out the Patient Decision Journey
December 18, 2019 13:30 - 36 minutes - 32.2 MBIf you truly want to bring patients in as stakeholders, we have to start at the beginning by understanding patients, their lifestyles and how the trial protocols are developed to reflect that. This session moderated by Dr Marilyn Metcalf, GSK and recorded at the 6th annual Patients as Partners US conference discusses understanding these dynamics and how they will help industry design appropriate initiatives that help meet its goals while aligning with patient's needs. This session addresses:...
FDA Patient Engagement Synergistic Efforts
December 17, 2019 15:00 - 44 minutes - 39.7 MBThis multi-center FDA podcast moderated by Anindita Saha, (CDRH) FDA and first recorded at the 6th annual Patients as Partners US conference, focuses on patient engagement and regulatory decision making. This podcast discusses: What is each center doing in terms of patient engagement?What initiatives are underway and what is the impact they will have?What are the synergistic efforts across the FDA centers?How are the patient involvement initiatives within the FDA moving the needle forward in...
The Democratization of Patient Data Ownership: Returning Results
December 16, 2019 13:30 - 1 hour - 64.7 MBIn this series, first recorded at the 6th annual Patients as Partners US conference, is led by Craig Lipset, formerly with Pfizer discusses the ideas of patients 'donating' data, patient data ownership, data rights, and why this is a disruptive force in advancing clinical trials, we address the need to ensure we have the appropriate systems, security, and the ability to withstand a Facebook/Cambridge Analytica Scenario. Craig is joined by Mark Scrimshire, NewWave/CMS and Bray Patrick-Lake, Du...
Cell & Gene Therapy Day Overview in 4 minutes
December 04, 2019 16:30 - 4 minutes - 2.84 MBIn this podcast, Kate Woda, Conference Director provides an overview of Cell & Gene Therapy Day in less than 4 minutes. Cell & Gene Therapy Day takes place on February 27, 2020 in New York City and convenes stakeholders spanning the science and business communities to report on the latest cell and gene therapy progress to fight a wider range of cancers beyond hematologic malignancies. Key Topic Areas: Landscape and Evolution to Marketplace: ProgressNew Scientific Frontiers in Cell Therapies...
2020 Immuno-Oncology 360° Summit Overview in 10 Minutes
December 04, 2019 15:30 - 11 minutes - 9.4 MBIn this 10 minute podcast, Kate Woda, Conference Director for IO360°, walks you through what to expect at 2020 IO360° Summit happening February 26-28, 2020 in New York City. IO360°convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers. The 6th annual IO360° Summit features the following plenaries: Discovery/Preclinical ScienceImaging AspectsClinical OperationsBispecificsBusiness Developments...
Fireside Chat with an R&D Veteran
December 03, 2019 17:30 - 35 minutes - 31.9 MBDr Jeffrey Chodakewitz, former EVP, Clinical Medicine and External Innovation, CMO at Vertex Pharmaceuticals, joins the Chief Medical Officer Summit for the first time to discuss his incredible journey as a CMO. Recorded at the 7th annual Chief Medical Officer Summit, Dr Chodakewitz sits down with Dr Julie Krop, AMAG Pharmaceuticals to discuss the following: The journeyPrioritizing resourcesSuccesses and failuresOvercoming hurdlesCareer decisionsTransitioning from large pharma to small biotec...
Designing Clinical Trials for Gene Therapy - A Paradigm Shift
December 03, 2019 13:00 - 41 minutes - 37 MBThis session, recorded at the 7th annual Chief Medical Officer Summit and moderated by Dr Martin Childers, Asklepios BioPharmaceutical, discusses designing clinical trials for gene therapy. Topics covered include: How to utilize adaptive trial design within the specific context of a gene therapy - are there any unique aspects of development conducive to this approach?How to ensure flexibility when pushing for an accelerated pathway?Communicating pros and cons of development options and your ...
Case Study: Life of a Chief Medical Officer Pre and Post IPO
December 02, 2019 18:30 - 32 minutes - 29.1 MBIn this talk, first recorded at the 7th annual Chief Medical Officer Summit, Dr Tal Zaks, Chief Medical Officer, Moderna Therapeutics shares his experience and lessons learned through one of the biggest transitions a Chief Medical Officer can make in biotech: Expanding the role of the CMO to meet the requirements of a public companyInsights into the experienceManaging growthWhat role does the CMO have in articulating the data of clinical trials What role does the CMO have in business developm...
How the CMO of Sage Therapeutics Positioned a New Indication for FDA Approval
December 02, 2019 13:00 - 37 minutes - 33.5 MBIn this session recorded at the 7th annual Chief Medical Officer Summit, Dr Steve Kanes, Chief Medical Officer, Sage Therapeutics, discusses how a company considered as an "up and comer" in the Cambridge biotech sector navigated the development and approval of the first treatment specifically designed for postpartum depression. Learn more at theconferenceforum.org
Addressing the Talent Gap in Biotech - Recruit and Retain
December 02, 2019 01:00 - 38 minutes - 34 MBIn an increasingly competitive market, there is a growing need for efficiency in attracting and retaining top talent. This session, recorded at the 7th annual Chief Medical Officer Summit, and moderated by Dr Julie Krop, AMAG Pharmaceuticals, addresses the following: How to source talent; pros and cons of recruiters versus word-of-mouthHow to make the work environment optimal to keep employees satisfiedHow to compete with the competition banging on the doorHow to ease or address relocation c...
How to Navigate the Development Path from CMO to CEO
December 01, 2019 18:00 - 29 minutes - 26.2 MBFirst recorded at the 7th annual Chief Medical Officer Summit, this session provides insight in what it takes and how to navigate and what to expect in the CEO role. Moderated by Dr Zain Kassam, Finch Therapeutics, this panel discusses: How can a CMO position themselves as a corporate leader?How to build a network of advisors and who should it include? Panelists include: Aoife Brennan, MB, BCh, BAO, MRCPI, SynlogicGreg Fiore, MD, Sollis Therapeutics Learn more at theconferenceforum.org
How do Patients Become Partners in the Sharing of Data to Advance Science?
November 06, 2019 13:00 - 23 minutes - 20.6 MBIn this podcast, hear a session from the 2019 Patients as Partners EU conference on How do Patients Become Partners in the Sharing of Data to Advance Science? How to encourage the sharing of suitably anonymized data to further medicines development for the benefit of patients?What are the barriers/issues? Public mistrust of pharma? Language, medical records versus coded data? Speakers: Natalie Banner, PhD, Understanding Patient Data Lead, Wellcome Trust Richard Stephens, Patient/Consumer Le...
Best Practices for Pharma - Patient Advocacy Partnerships
November 05, 2019 13:00 - 27 minutes - 24 MBIn this podcast, hear a panel discussion presented at the 2019 Patients as Partners EU conference on Best Practices for Pharma - Patient Advocacy Partnerships. Pharma and advocacy representatives discuss: • Advocacy point of view on is what pharma is doing in clinical trials and medicines development truly patient-centric? • How can advocacy groups work with the pharmaceutical industry to improve the clinical trial process? • How can advocacy get their foot in the door at pharma? Pharma’s...
Merck's Next Phase of Patient Centricity in R&D
November 04, 2019 13:00 - 23 minutes - 20.5 MBIn this podcast, hear a session from the 2019 Patients as Partners EU meeting where Merck's Vanessa Pott presented a case study on Innovative Medicines Development and Merck KGaA's next phase of Patient Centricity in R&D. The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020 in London, UK. To learn more about the program and patient centricity in R&D, visit theconferenceforum.org.
Clinical update on AMG 420, an anti-BCMA BiTE®
November 01, 2019 16:00 - 24 minutes - 21.3 MBIn this talk, recorded at the 5th annual IO360° Summit, Dr Alex Minella, Amgen, provides a clinical update on AMG 420, an anti-BCMA BiTE® This talk addresses the: Summary of IND enabling preclinical studiesFirst-in-human trial designFirst-in-human trial data (safety, efficacy) Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com
Connecting Employee-Centric Culture to Patient-Centric Culture
November 01, 2019 12:00 - 21 minutes - 18.4 MBAt the 2019 Patients as Partners EU meeting, Servier's Lode Dewulf presented a discussion on connecting employee-centric culture to patient-centric culture. This presentation covered the following points: • What impact can engaged employees have on positioning the company as the preferred partner for patients and other collaborators? • How can this be done? And for what purpose? • How do you engage your employees and empower them to implement patient involvement strategies? • Inspiring em...
Eliciting Patient Experience Data to Understand Medicines Benefits/Disadvantages
October 31, 2019 12:00 - 21 minutes - 18.4 MBIn this podcast, listen to a session from the 2019 Patients as Partners EU conference on Sanofi Eliciting Patient Experience Data During Clinical Trials to Better Understand Patient-Perceived Benefits and Disadvantages of their Drugs. Dr Aude Roborel de Climens, PRO/COA Lead at Sanofi discusses how they capture patient experiences during clinical research and the benefit of collecting direct patient feedback. More specifically, she presents how they evaluate and analyse qualitatively and qua...
Understanding the Language of Patients - The Value of Health Literacy
October 30, 2019 12:00 - 22 minutes - 19.4 MBIn this podcast, hear a session presented at the 2019 Patients as Partners EU conference on the Process to Understand the Language of Patients and the Value of Health Literacy. Who is responsible for delivering the why and how of getting involved in medicines development? Pharma, regulators or advocacy groups?What practical goals can the industry set to effect change?How are we communicating the trial information to patients and care partners to help them understand and make informed decision...
UCB and Parkinson's UK Collaboration Improve a Trial through Patient Involvement
October 29, 2019 12:00 - 33 minutes - 29.9 MBIn this podcast, hear a case study from the 2019 Patients as Partners EU conference on UCB and Parkinson's UK Working Together to Improve a Phase 2 Trial through Patient Involvement. In 2018, UCB and Parkinson’s UK co-developed a workshop to enable the UCB research team to work together with people affected by Parkinson’s to discuss and develop a potential phase 2 clinical trial. The aim of the workshop was to better understand people’s thoughts on clinical trials and get feedback on key fea...
Improving T Cell Therapies via Next Generation Technologies
October 17, 2019 04:00 - 49 minutes - 44.2 MBThe pipeline of adoptive T-cell therapies and other cell based immuno-oncology programs continues to expand with a number of modifications and improvements to the first generation programs. These platforms include improved spcificty and delivery - including non-viral platforms, targeting of multiple antigens, editing constructs, and a variety of strategies to address toxicity and the tumor microenvironment. This panel of experts, moderated by Dr Gbola Amusa, Chardan and recorded at the 5th an...
Monetizing Science: Turning an Asset into Value through IPOs
October 16, 2019 17:30 - 36 minutes - 32.7 MBThis panel moderated by Dr Andrew Baum, Citi and recorded at the 5th annual IO360° Summit discusses the preparation of an IPO, straight licensing with the transition to a public company and decision making on prioritization within portfolios. Panelists include: David Epstein, Flagship PioneeringDan Passeri, Cue Biopharma Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com
IDO Changes the T-cell Balance in the Tumor Microenvironment
October 16, 2019 16:30 - 17 minutes - 15 MBIn this talk recorded at the 5th annual IO360° Summit, Dr Charles Link Jr, Newlink Genetics, addresses how IDO changes the T-cell balance in the tumor microenvironment. This talk addresses how: IDO creates local immunosuppression by increasing T regulatory cellsIDO often works in concert with PDL-1 mediated immunosuppressionIDO mediated T-cell immunosuppression leads to poor prognosis in melanoma Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crow...
Insights from Deal Trends: Betting on Tumor Immunology
August 29, 2019 18:30 - 22 minutes - 20.1 MBIn this podcast from the 2019 Immuno-Oncology 360° conference, Cello Health BioConsulting's EVP, Oncology Practice Head, Dr Jeff Bockman discusses deal-making and investments in the I-O space to see what can be learned about the expanding and shifting landscape of BioPharma and investor interest by examining who is placing what kinds of bets on which targets and modalities, at what stage and with what terms. Additional topics include: Where are the next big paradigm shifts going to be?Where ...
Living with Alzheimer’s from a Young Patient's Perspective
August 23, 2019 17:30 - 19 minutes - 17 MBPharma Talk Radio producer, Valerie Bowling recently spoke with a young Alzheimer's patient, Jeff Borghoff. Jeff was officially diagnosed with Alzheimers in 2016 and is an active and patiionate patient advocate. Jeff generously shares his experience from diagnosis, to the experience of a clinical trial to his work in advocacy. Jeff will be speaking at the Patients as Partners conference on June 29-30, 2020 in Philadelphia. For more information, visit theconferenceforum.org We look forward t...
Organizational and Digital Restructuring to Scale Mobile Clinical Trials
August 23, 2019 13:00 - 22 minutes - 19.7 MBIn this podcast from the 2018 Mobile in Clinical Trials conference, Mohammad Ali, Global Head Digital Trials- Global Clinical Operations, Boehringer-Ingelhiem and Joe Dustin, Principal, Mobile Health, Medidata Solutions discussed the internal infrastructure that is required for the successful scaling of mobile/digital tools in clinical trials. The discussion focuses on how to come to terms with the demand of data, understanding the skill set required to purposefully use the data and implemen...
How to Align the Promise of Technology with the Patient Voice
August 22, 2019 21:30 - 35 minutes - 31.9 MBIn this podcast from the 2018 Mobile in Clinical Trials conference, patient advocate, Cindy Geoghegan sat down with Dr Daniel Karlin, CEO, Healthmode and Deanna Lennon, Director of Business Development, Medable Inc for a discussion on aligning the promise of technology with the patient voice. The panel explores patient perspective on being monitored continuously and pharma perceptions of what patients want versus what patients really want. Speakers: Cindy Geoghegan, Patient Advocate ...
The Role of Digital Biomarkers and the Impact on Drug Delivery
August 22, 2019 16:30 - 18 minutes - 16.3 MBIn this podcast from the 2018 PODD: Partnership Opportunities in Drug Delivery conference, Dr Christopher Kovalchick, Chief Engineer, Drug Delivery & Devices R&D Innovation at Eli Lilly and Company presented on incorporating of digital monitoring biomarkers into drug delivery. More specifically a framework is presented which stratifies key components and advances the concept of contextualized biomarkers. The framework codifies how direct, indirect, composite and contextualized composite data...
PODD: Partnership Opportunities in Drug Delivery 2019 Overview in 4 Minutes
August 20, 2019 15:00 - 5 minutes - 3.74 MBIn this podcast, Valerie Bowling, Director of PODD, walks you through what to expect at PODD 2019 in under 4 minutes. The 9th annual PODD conference features the following: Building a Company around a Transformative Drug Delivery Invention with MIT's Dr Robert Langer, Dr Sangeeta Bhati, Dr Giovanni Traverso and Harvard Medical School's Dr Jeffrey Karp.Modality Fluid Development: Tales of Evolving Pipelines and Drug Delivery Solutions with Merck's, VP, Pharmaceutical Sciences, Dr Allen Templet...
A Patient Perspective on Living with Parkinson's Disease and the GDNF Trial
August 19, 2019 15:00 - 25 minutes - 22.9 MBIt is estimated that between 7-10 million people, globally have Parkinson's disease. Our guest on Pharma Talk Radio, Lesley Gosden is living with Parkinsons and she is an outstanding patient advocate, who experienced the GDNF clinical trial. In this podcast discussion, our guest will give us an insight into living with Parkinson's, about the GDNF clinical trial, lessons for all stakeholders and in particular how the success rate of clinical trials could be improved from the patient’s point o...
The Future of Mobile Data in Clinical Trials: Challenges and Opportunities
August 15, 2019 17:30 - 16 minutes - 14.6 MBIn this podcast from the 2018 Mobile in Clinical Trials conference, Dr Paul Glimcher, Julius Silver Professor of Neural Science and Physiology at NYU alongside Dr Daniel Karlin, CEO at Healthmode presented on the future of mobile data in clinical trials. Drs Glimcher and Karlin discussed this rapidly evolving space with an emphasis on the barriers and opportunities in the mobile health arena. More specifically: • What are the Barriers to gathering an incorporating Mobile data into clinical ...
Eli Lilly: How to Launch Multiple Mobile Devices in a Hybrid Setting
August 15, 2019 17:00 - 28 minutes - 24.8 MBIn this podcast from the 2018 Mobile in Clinical Trials conference, Eli Lilly's Joseph Kim, Sr Advisor, Clinical Operations and Digital Registry, Digital Health Office | Translational Technology & Innovation, reported on incorporating a variety of mobile devices – including a smart phone, smart insulin pens, connected devices, mifi, and laptops, into a clinical trial. Considerations and lessons learned for: • Connecting all the devices • Implementation differences between traditional vs si...
Pfizer’s Atopic Dermatitis Clinical Trial with Digital Wearable Technology
August 08, 2019 14:00 - 23 minutes - 20.4 MBIn this podcast from Mobile in Clinical Trials 2018, Pfizer's Project Team Lead, Early Clinical Development, Digital Medicine, Dr Carrie Northcott speaks about considerations and lessons learned from the validation, verification and use of digital wearable technology in a Atopic Dermatitis Clinical Trial and some of Pfizer's forward-leaning work in decision making around novel digital endpoints. Dr Northcott is coming back to Mobile 2019 to share results and next steps on this trial. Spea...
Merck’s Digital Health and Al Strategy: Progress Report
August 07, 2019 14:00 - 15 minutes - 13.2 MBIn this session presented at the Mobile in Clinical Trials 2018 conference, Merck's Kai Bode and Jyoti Shah share an exciting update on the company's progress in implementing a digital health and AI strategy. Session takeaways include: What Merck is doing in digital health and AIExternal collaborations on AISmart trial initiative to enable patient-centric studies Kai Bode is returning to Mobile 2019 to share an update on Merck's digital strategy 2.0 and how they are engineering for scale. Sp...
How Digital Biomarker Innovation is Modernizing Clinical Endpoints
July 31, 2019 12:00 - 17 minutes - 14.7 MBIn this session from DPharm 2018, Roche provides an update on the company's progress in how they are collecting data with sensor technology and turning it into a clinically meaningful endpoint with multiple indications, including Parkinson's disease and Multiple Sclerosis. Session takeaways include: Understand what Digital Biomarker innovation means for the future of clinical development and potentially personalized healthcare.Be inspired to use mobile sensors technology in the context of cli...
Regenerative Medicine as a Disrupter in Clinical Trials
July 30, 2019 12:00 - 32 minutes - 28.6 MBThis is a keynote session from DPharm 2018. Dr Atala, a renowned key opinion leader on the topic of regenerative medicine, brings the DPharm audience a fascinating presentation on how it's possible to reduce the number of patients needed in clinical trials with the advancement of regenerative medicine, and how regenerative medicine can improve accuracy and speed up the clinical trial process. Speaker: Anthony Atala, MD, Director, Wake Forest Institute for Regenerative Medicine The 9th annu...
6th Annual Mobile in Clinical Trials: What to Expect in 4 Minutes
July 29, 2019 14:00 - 4 minutes - 3.59 MBThis 4 minute podcast summarizes what you can expect at the 6th annual Mobile in Clinical Trials conference. This event provides sessions on the latest progress in applying mobile applications and patient-facing technologies to connect and empower patients, while obtaining better outcomes in drug development. The conference takes place September 16, 2019 at the Renaissance Boston Waterfront Hotel, Boston, MA. The program is co-chaired by Bayer’s Michelle Shogren, Director of Innovation, Phar...
Estonia, The Digital Republic: Where Patients Own Their Data
July 29, 2019 12:00 - 36 minutes - 32.2 MBAn Insight into Our Possible Future Faster than You Think This keynote session was presented at the 2018 DPharm conference. Estonia is now a digital republic with a virtual government, blockchained and secure. Our keynote guest from Estonia tells us how Estonia became the fastest country in the world to go digital. Its 1.3 million citizens pay with their mobile phones, have their health records stored in the digital cloud, and filed their annual tax return online in five minutes. This sessio...
Co-Creating the Industry's Scalable Solution for EHR
July 28, 2019 12:00 - 29 minutes - 26 MBIn this session presented at the 2018 DPharm conference, Rob Goodwin and Amy Nordo share an exciting new collaboration - including industry and academia, as well as health authorities and leading technologists - positioned to break through the barriers to allow the power and the promise of eSource across companies and medical centers. The potential for eSource has been discussed for years, but realizing its promise has been difficult. While most health data today can be captured within elect...
Bringing Blockchain to Life: Digitizing Clinical Supply Chain in Trials
July 27, 2019 13:00 - 22 minutes - 19.6 MBIn this podcast from DPharm 2018, Pfizer's VP of Clinical Supply Chain, Michael Ku, speaks about some of Pfizer's earliest work making blockchain real as well as some of their forward-leaning work digitizing supply chain for clinical trials. The 9th annual DPharm conference will take place on September 17-18, 2019 in Boston, MA. Learn more at theconferenceforum.org.
Bayer: Virtual Assistants for Sites and Patients in Clinical Trials
July 26, 2019 12:00 - 15 minutes - 13.5 MBIn this podcast from DPharm 2018, Bayer shares how they use virtual assistants and chatbots to support study teams, research sites, and patients. Learn how they are doing this and what you should consider. Speaker: Michelle Shogren, Head of Innovation, Portfolio & Operations, Bayer The 9th annual DPharm conference will take place on September 17-18 in Boston, MA. Learn more at theconferenceforum.org.
DPharm: Disruptive Innovations in Clinical Trials 2019 Overview in 5 Minutes
July 25, 2019 13:00 - 5 minutes - 4.46 MBIn this podcast, Valerie Bowling, Director of DPharm, walks you through what to expect at DPharm 2019 in under 5 minutes. This is the 9th annual DPharm conference featuring keynotes from: Dr Scott Gottlieb, 23rd Commissioner of the FDATakeda’s CMO, Dr Andy PlumpMerck’s VP of Global Operations, Dr Mark TraversCellarity's Chief Data Officer, Milind KamkolkarStarbucks' Design Director of Global Digital Products, Robert MercerFast Company's Deputy Editor, David LidskyHealthgrades' Founder, Kerry ...